Expand RPTX Menu
RPTX MENU

RPTX Latest Press Releases

-- December 18, 2025 --

Halper Sadeh LLC Encourages UBFO, CWBC, RPTX Shareholders to Contact the Firm to Discuss Their Rights PRNewswire 6:12 PM

-- December 17, 2025 --

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--RPTX, FRGE, CSGS, FIZN PRNewswire 4:35 PM

-- December 8, 2025 --

Halper Sadeh LLC Encourages CFLT, EB, RPTX Shareholders to Contact the Firm to Discuss Their Rights Globe Newswire 12:42 PM

-- December 4, 2025 --

Halper Sadeh LLC Encourages GDOT, KVUE, RPTX, KMB Shareholders to Contact the Firm to Discuss Their Rights Globe Newswire 1:24 PM

-- December 2, 2025 --

Halper Sadeh LLC Encourages RPTX, AXTA, BLFY, GDEN Shareholders to Contact the Firm to Discuss Their Rights Globe Newswire 9:02 AM

-- November 28, 2025 --

Halper Sadeh LLC Encourages THS, RPTX, AXTA Shareholders to Contact the Firm to Discuss Their Rights PRNewswire 12:39 PM

-- November 27, 2025 --

HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - RPTX, AXTA, WTG and SEMR PRNewswire 11:13 PM
Halper Sadeh LLC Encourages RPTX, THS, RMBI Shareholders to Contact the Firm to Discuss Their Rights Globe Newswire 6:47 PM

-- November 20, 2025 --

Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc. Business Wire 5:25 PM

-- November 18, 2025 --

Halper Sadeh LLC Encourages RPTX and SEE Shareholders to Contact the Firm to Discuss Their Rights Globe Newswire 7:44 AM

-- November 17, 2025 --

Halper Sadeh LLC Encourages RPTX, SEE, CDTX, MRSN Shareholders to Contact the Firm to Discuss Their Rights PRNewswire 12:00 PM
Key Catalysts Emerge in Oncology, Synthetic Biology, and M&A Activity as Markets Open Globe Newswire 10:48 AM

-- November 14, 2025 --

RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders Business Wire 10:59 PM
Shareholder Alert: The Ademi Firm investigates whether Repare Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders PRNewswire 7:56 PM
Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc. Business Wire 4:44 PM

-- October 13, 2025 --

Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Business Wire 4:05 PM

-- August 8, 2025 --

Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results Business Wire 7:00 AM

-- August 6, 2025 --

OMass Therapeutics Appoints Carol A. Schafer as Non-Executive Director and Chair of the Audit Committee Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes